Home > Boards > US Listed > Biotechs >

Opgen (OPGN)

Add OPGN Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 5/15/2022 10:30:50 PM - Followers: 73 - Board type: Free - Posts Today: 0

Vexing problems oftimes lead to creative solutions. OpGen's robust ingenuity is a case in point.

Problem: "Antibiotic resistance is a global threat. There is no system in place to track antibiotic resistance globally. Without urgent action, many modern medicines could become obsolete, turning even common infections into deadly threats." -U.S. Center for Disease Control

Enter OpGen, Inc.   Press Releases

OpGen, Inc. (Gaithersburg, MD, USA) (Nasdaq OPGN) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to guide clinicians with rapid and actionable information about life-threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDRO). Subsidiaries include Curetis GmbH and
Ares Genetics GmbH*. 
Partners include Sandoz, QIAGEN, Merck, HIPS, Curetis, BGI, Max Perutz Labs Vienna, MGI. Learn more

OpGen’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, PNA FISH, Quick Fish, Acuitas® Lighthouse, and the ARES Technology Platform. The Ares Technology Platform includes ARESdb (db=database) that uses NGS (next generation sequencing) technology and AI-powered bioinformatics solutions to predict antibiotic response (resistance). Artificial intelligence based DNA testing revolutionizes infectious disease diagnostics and therapeutics.* Patient outcomes improved; costs reduced. Learn more

"Time is of the essence in cases of severe infections, not infrequently a question of life or death, and knowing what not to prescribe is as important as knowing what to prescribe."
 OpGen Corporate Overview 06-Oct-2020  yes (Recommended viewing)

*02Oct2020 OpGen's wholly owned Ares Genetics GmbH* (Vienna) won the Austria State Prize for innovation with their Project "ARESupa- Molecular Antibiotic Resistance Diagnostics using Artificial Intelligence - With a (Ares Genetics) universal pathogen test, antibiotic resistance from germs can be predicted quickly and accurately." yes

OpGen subsidiary Ares Genetics, which combines Next Generation Sequencing (NGS) with ARESdb, is the world‘s most comprehensive database on the genetics of antibiotic resistance. ARESdb is also the world’s largest database of genetic antibiotic resistance markers and predictive AMR panels. ARESdb contains thousands of whole genome sequenced clinical isolates collected from more than 200 centers globally. ARESdb combines broad resistance profiles with high-quality genetic information and enables pathogen identification with up to >99% accuracy and antibiotic resistance detection with ~98% accuracy. ARESdb covers 30 years of emerging antibiotic resistance to accurately detect AMR and combines deep whole-genome sequencing data with antibiotic resistance profiles continuously expanded. Partners include Sandoz, QIAGEN, Merck, HIPS, Curetis, BGI, Max Perutz Labs Vienna, MGI.

                                                   Fast & Simple Syndromic Testing for Severe Infections -- Improving Patient Outcomes yes
                                                           Detects pathogens rapidly, including associated antibiotic resistance genes yes
                                                  Antibiotic resistant microorganisms are a global health threat (Per CDC, WHO, US GAO)

                                                                 Our UNYVERO A50 IS FDA APPROVED yes UNYVERO FLYER (Recommended viewing)  

With the Unyvero A50 Solution, OPGen's wholly owned subsidiary Curetis has developed a molecular diagnostics system for reliable and extremely rapid diagnosis of severe infectious diseases in under 5 hours versus up to 96 hours using current methods. The system uses powerful multiplex PCR technology and syndromic testing to detect a wide variety of microorganisms, antibiotic resistance markers, or toxins.



Unyvero A50 Applications for Major Infectious Disease


    HPN- Hospitalized Pneumonia                                                                
HPN Solution 

     BCU — Blood Culture  
   Analyzes the DNA of 103 pathogens & resistance genes from a
   positive blood culture for fast diagnostics of blood stream infections.

    BCU Solution 

     IAI — Intra-Abdominal Infection
    IAI Solution 

     UTI — Urinary Tract Infection

     UTI Solution 

      ITI — Implant & Tissue Infection       
    ITI Solution 


Unyvero A50 System
Unyvero A50 Cartridge
Unyvero A30 RQ in development

*OpGen Partner Curetis BGI COVID-19 Rapid Test Kits approved by US FDA  March 29, 2020
"The kits are being used in 70 countries and regions including Japan, Brunei, Thailand, The United Arab Emirates, Egypt and Peru."
*OpGen Expands Partnership with New York State Department of Health and IDC to Detect Antimicrobial-Resistant Infections  June 03, 2020
*OpGen Releases Preliminary Data Demonstrating its Unyvero HPN Panel for Pneumonia Identifies Life-Threatening Bacterial Co-Infections in COVID-19  Patients in Just Five Hours  June 09, 2020
*Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America July 13, 2020
*OpGen Co-Markets COVID-19 Antibody Test Kit  August 09, 2020
*OpGen Announces CE-IVD Marking and Commercial Launch in Europe of its Own Developed Molecular Diagnostic SARS-CoV-2 Kit with PULB for Detection of the Virus Causing COVID-19  August 20, 2020
*Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for Investigation of Genetic Antimicrobial Resistance Mechanisms and Molecular Susceptibility Testing  September 16, 2020
*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OPGN News: Quarterly Report (10-q) 05/13/2022 12:55:56 PM
OPGN News: H.C. Wainwright Thinks OpGen’s Stock is Going to Recover 05/13/2022 02:26:44 AM
OPGN News: Current Report Filing (8-k) 05/12/2022 12:45:33 PM
OPGN News: OpGen Reports First Quarter 2022 Financial Results and Provides Business Update 05/12/2022 12:15:00 PM
OPGN News: OpGen to Provide Business Update and Financial Results for the First Quarter 2022 on May 12th at 4:30 p.m. Eastern Time 04/28/2022 03:30:00 AM
#2322  Sticky Note $OPGN # 2 OpGen Co-Markets COVID-19 Antibody Test Kit mick 08/09/20 06:29:05 PM
#2581   Schacht's repeat record of 99% retail losses. Olllie chillswills37 05/15/22 10:30:50 PM
#2580   ALL SHAREHOLDERS make sure you have put glamg 05/11/22 01:09:17 PM
#2579   It Takes a Pillage--suggested movie title of OPGN chillswills37 05/04/22 02:40:53 PM
#2578   OpGen Inc (OPGN) mick 05/01/22 04:29:04 PM
#2577   $10,000 invested 2015 would be $2.30 today. Chart below. chillswills37 04/28/22 09:30:35 PM
#2576   Ollie won't sell OPGN; no more milllion$ salary chillswills37 04/28/22 02:27:58 PM
#2575   Proxy vote info here. Voting NO sends a chillswills37 04/26/22 05:05:51 PM
#2574   $OPGN Ollie Schacht is through. The Big Boys chillswills37 04/26/22 10:57:29 AM
#2573   Cutting edge, genius biotechnologies, but the wrong person chillswills37 04/25/22 03:35:14 PM
#2572   $OPGN Tweets more cutting-edge biotech from Ares Genetics: ARESid chillswills37 04/25/22 09:18:11 AM
#2571   How Sandoz chess move affirms OPGN Ares Genetics chillswills37 04/23/22 02:28:58 PM
#2570   $OPGN They're buying. April 22, 2022 Arete Wealth chillswills37 04/22/22 01:22:05 PM
#2569   $OPGN Why is bioMérieux's acquisition bullish for OpGen? chillswills37 04/21/22 10:14:54 PM
#2568   OPGN OpGen Inc mick 04/21/22 04:48:21 PM
#2567   $OPGN $NVS Sandoz collaboration extended to Jan 2025. chillswills37 04/21/22 03:46:12 PM
#2566   $OPGN Volume before news. chillswills37 04/21/22 12:20:25 PM
#2565   Yi Chen aktivating BEIJING BILL 04/21/22 11:55:12 AM
#2564   .75 now BEIJING BILL 04/21/22 11:55:03 AM
#2563   OPGN OpGen Inc mick 04/21/22 10:36:25 AM
#2562   there ve go mick, .69 again sanks to BEIJING BILL 04/21/22 10:02:42 AM
#2561   OPGN OpGen Inc mick 04/20/22 09:35:50 AM
#2560   OpGen’s Subsidiary Ares Genetics Commercially Launches New Sequencing BEIJING BILL 04/20/22 08:50:05 AM
#2559   OpGen Inc (OPGN) mick 03/12/22 03:11:30 PM
#2558   This biotech is almost ready. FDA approval, product BEIJING BILL 02/21/22 09:20:59 PM
#2557   OpGen Inc (OPGN) mick 02/06/22 05:14:09 PM
#2556   OpGen Inc (OPGN) mick 02/06/22 05:13:55 PM
#2555   Bounce on 01-27? Edison, London Exchange, TaylorWessing partnering chillswills37 01/26/22 03:40:57 PM
#2554   Event schedule Edison Global Conf. OpGen presentation slotted chillswills37 01/21/22 06:43:40 PM
#2553   $OPGN Coming up Tuesday Jan 25: OpGen to chillswills37 01/21/22 03:04:01 PM
#2552   $OPGN Marketbeat: "The main competitors of OpGen include chillswills37 01/20/22 02:59:50 PM
#2551   https://www.otcmarkets.com/stock/OPGN mick 01/02/22 06:26:22 PM
#2550   Some of this doubtless is tax loss selling: chillswills37 12/21/21 12:15:11 PM
#2549   https://www.otcmarkets.com/stock/OPGN mick 12/11/21 06:34:14 PM
#2548   Can't believe that I am the only 1 Jiminy Cricket 11/24/21 10:57:06 AM
#2547   Looks like they might finally let her run........ Jiminy Cricket 11/23/21 03:04:05 PM
#2546   RSI is at 19..........the pop here is going Jiminy Cricket 11/18/21 01:49:34 PM
#2545   Looks good for next week. RSI oversold, good Jiminy Cricket 11/12/21 03:31:57 PM
#2544   OpGen Inc (OPGN) mick 11/07/21 12:53:43 PM
#2543   I don't think it's ever a good thing..... Jiminy Cricket 11/05/21 12:21:32 PM
#2542   Increasing AS. Not good for investors. boston127 11/04/21 08:23:41 PM
#2541   $OPGN Commercial launch of unique AREScloud app. Uses chillswills37 10/21/21 11:08:43 AM
#2540   ST heavily bearish, often a bullish sign. Time chillswills37 10/20/21 08:49:10 PM
#2539   Silver lining in timing of meeting? The special chillswills37 10/19/21 08:35:38 PM
#2538   FDA clearance doc image Gene Panel. FDA decision chillswills37 10/04/21 04:40:17 PM
#2537   Nice bull trap today.... BigFortune 10/04/21 04:34:58 PM
#2536   OpGen shares are trading higher after the company crudeoil24 10/04/21 07:56:59 AM
#2535   OpGen Inc (OPGN) mick 09/22/21 08:11:28 PM
#2534   Bull mania crushed, catching some shares at these chillswills37 09/14/21 09:53:14 AM
#2533   Some serious selling. Green again. boston127 09/08/21 02:08:18 PM
#2532   Up and green - again. boston127 09/07/21 10:15:56 AM
Consent Preferences